Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Business & Regulation

Business & Regulation Profession

Demystifying Cancer R&D

| Maryam Mahdi | 5 min read

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Business & Regulation Marketing

Patients, Be Not Afraid

| Ben Beckley | 2 min read

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

Business & Regulation Digital Technologies

Collaborating for a Cause

| Maryam Mahdi | 6 min read

Can AI help us better understand and define chronic pain?

Business & Regulation Digital Technologies

Making the Most of Big Data

| Devesh Verma, Brian Gibbs | 4 min read

How AI can be leveraged to improve patient acquisition.

Business & Regulation Digital Technologies

Intelligence By Design

| Maryam Mahdi | 13 min read

Explore the potential of AI with industry experts.

Business & Regulation Business Practice

Finding the True Meaning of Disruption

| Noel Maestre

Disruptive technologies are often talked about in pharma circles. But when it comes to AI, what long-term impact will it have?

Business & Regulation Business Practice

A Certain Shade of Green

| Andrew Toher | 5 min read

Pharmaceutical manufacturers burn through huge amounts of energy – so they need sustainable energy strategies.

Business & Regulation COVID-19

VIDEO: From Quality Control to Cold Chain

| Sponsored by Dätwyler

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

Business & Regulation Trends & Forecasts

How COVID-19 Saved Pfizer’s Revenue

| Stephanie Sutton | 3 min read

Our animated chart illustrates Pfizer’s changing fortunes – and the significant contribution its COVID-19 efforts have made to revenues.

Business & Regulation Digital Technologies

Out With The Old

| Angelo Stracquatanio

To see true progress, pharma manufacturers will have to do away with their legacy systems.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register